Finance

Lists
Why is 81X up 2,84%?
Dive Deeper
81X:FRA
LifeTech Scientific Corp
₮0,14
+2,84%
(+0,0040) 1D
12 āš•.āšĨ., 22 āŧ‚āšĄāš‡ 0 āš™āšēāš—āšĩ 00 āš§āšīāš™āšēāš—āšĩ GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 81X...
Open
₮0,14
High
₮0,14
Low
₮0,14
Mkt. cap
6,83Â āš•āš·āŧ‰
Avg. vol.
0,00
Volume
0,00
52-wk high
₮0,23
52-wk low
₮0,13
No. of employees
1Â āšžāšąāš™
Open
₮0,14
High
₮0,14
Low
₮0,14
Mkt. cap
6,83Â āš•āš·āŧ‰
Avg. vol.
0,00
Volume
0,00
52-wk high
₮0,23
52-wk low
₮0,13
No. of employees
1Â āšžāšąāš™
News stories
From web sources and news partners
www.marketscreener.com
www.marketscreener.com
·
1 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
Nextdoor Holdings, Inc. Primary Exchange Listing will Change to Nasdaq Capital Market from New York Stock Exchange
Cryptonews.net
Cryptonews.net
·
16 āš™āšēāš—āšĩāšāŧˆāš­āš™
Evernorth Hits Nasdaq With 473 Million XRP as XRPN Trading Begins
CNBC
CNBC
·
3 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
Jim Cramer says the bull market's remarkable 4-year run offers a crucial lesson for investors
About LifeTech Scientific Corp
CEO-
Employees1,25Â āšžāšąāš™
Founded1999
Headquarters-
SectorMedical device
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
āš.āš. 2025
āš—.āš§. 2025
āšĄ.āš™. 2026
āšĄāšī.āš–. 2026
Revenue
346,54 āšĨāŧ‰āšēāš™
346,54 āšĨāŧ‰āšēāš™
300,42 āšĨāŧ‰āšēāš™
300,42 āšĨāŧ‰āšēāš™
Cost of goods sold
85,86 āšĨāŧ‰āšēāš™
85,86 āšĨāŧ‰āšēāš™
67,47 āšĨāŧ‰āšēāš™
67,47 āšĨāŧ‰āšēāš™
Cost of revenue
85,86 āšĨāŧ‰āšēāš™
85,86 āšĨāŧ‰āšēāš™
67,47 āšĨāŧ‰āšēāš™
67,47 āšĨāŧ‰āšēāš™
Research and development expenses
64,10 āšĨāŧ‰āšēāš™
64,10 āšĨāŧ‰āšēāš™
66,08 āšĨāŧ‰āšēāš™
66,08 āšĨāŧ‰āšēāš™
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
119,87 āšĨāŧ‰āšēāš™
119,87 āšĨāŧ‰āšēāš™
162,66 āšĨāŧ‰āšēāš™
162,66 āšĨāŧ‰āšēāš™
Operating expense
178,35 āšĨāŧ‰āšēāš™
178,35 āšĨāŧ‰āšēāš™
221,75 āšĨāŧ‰āšēāš™
221,75 āšĨāŧ‰āšēāš™
Total operating expenses
264,21 āšĨāŧ‰āšēāš™
264,21 āšĨāŧ‰āšēāš™
289,22 āšĨāŧ‰āšēāš™
289,22 āšĨāŧ‰āšēāš™
Operating income
82,32 āšĨāŧ‰āšēāš™
82,32 āšĨāŧ‰āšēāš™
11,19 āšĨāŧ‰āšēāš™
11,19 āšĨāŧ‰āšēāš™
Other non operating income
-57,50Â āšžāšąāš™
-57,50Â āšžāšąāš™
-
-
EBT including unusual items
55,83 āšĨāŧ‰āšēāš™
55,83 āšĨāŧ‰āšēāš™
-5,89 āšĨāŧ‰āšēāš™
-5,89 āšĨāŧ‰āšēāš™
EBT excluding unusual items
76,67 āšĨāŧ‰āšēāš™
76,67 āšĨāŧ‰āšēāš™
-8,65 āšĨāŧ‰āšēāš™
-8,65 āšĨāŧ‰āšēāš™
Income tax expense
20,52 āšĨāŧ‰āšēāš™
20,52 āšĨāŧ‰āšēāš™
18,25 āšĨāŧ‰āšēāš™
18,25 āšĨāŧ‰āšēāš™
Effective tax rate
36,76%
36,76%
-309,94%
-309,94%
Other operating expenses
-5,21 āšĨāŧ‰āšēāš™
-5,21 āšĨāŧ‰āšēāš™
-6,98 āšĨāŧ‰āšēāš™
-6,98 āšĨāŧ‰āšēāš™
Net income
46,38 āšĨāŧ‰āšēāš™
46,38 āšĨāŧ‰āšēāš™
-17,17 āšĨāŧ‰āšēāš™
-17,17 āšĨāŧ‰āšēāš™
Net profit margin
13,38%
13,38%
-5,72%
-5,72%
Earnings per share
-
-
-
-
Interest and investment income
7,60 āšĨāŧ‰āšēāš™
7,60 āšĨāŧ‰āšēāš™
1,34 āšĨāŧ‰āšēāš™
1,34 āšĨāŧ‰āšēāš™
Interest expense
-37,50Â āšžāšąāš™
-37,50Â āšžāšąāš™
-95,00Â āšžāšąāš™
-95,00Â āšžāšąāš™
Net interest expenses
7,56 āšĨāŧ‰āšēāš™
7,56 āšĨāŧ‰āšēāš™
1,25 āšĨāŧ‰āšēāš™
1,25 āšĨāŧ‰āšēāš™
Depreciation and amortization charges
-
-
-
-
EBITDA
110,45 āšĨāŧ‰āšēāš™
110,45 āšĨāŧ‰āšēāš™
35,87 āšĨāŧ‰āšēāš™
35,87 āšĨāŧ‰āšēāš™
Gain or loss from assets sale
1,84 āšĨāŧ‰āšēāš™
1,84 āšĨāŧ‰āšēāš™
-
-
AI content may include mistakes. Learn more
āŧāš­āšąāššāš‚āš­āš‡ Google